|
KPNA4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.202200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5149699999939E-05 |
| Normal-vs-Stage2 |
3.597500E-02 |
| Normal-vs-Stage3 |
9.386800E-01 |
| Normal-vs-Stage4 |
6.696300E-02 |
| Stage1-vs-Stage2 |
3.022000E-01 |
| Stage1-vs-Stage3 |
2.681800E-03 |
| Stage1-vs-Stage4 |
4.971000E-01 |
| Stage2-vs-Stage3 |
1.431990E-01 |
| Stage2-vs-Stage4 |
9.281200E-01 |
| Stage3-vs-Stage4 |
2.357800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.821100E-04 |
| Normal-vs-AfricanAmerican |
5.542000E-03 |
| Normal-vs-Asian |
6.686800E-01 |
| Caucasian-vs-AfricanAmerican |
9.678200E-01 |
| Caucasian-vs-Asian |
6.322000E-01 |
| AfricanAmerican-vs-Asian |
6.406400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29439999999137E-05 |
| Normal-vs-Female |
6.001400E-01 |
| Male-vs-Female |
3.864300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.403100E-03 |
| Normal-vs-Extreme_Weight |
1.75069999999167E-05 |
| Normal-vs-Obese |
2.526300E-02 |
| Normal-vs-Extreme_Obese |
4.289900E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.218000E-01 |
| Normal_Weight-vs-Obese |
4.917400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.440600E-01 |
| Extreme_Weight-vs-Obese |
8.573800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.646000E-01 |
| Obese-vs-Extreme_Obese |
3.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.506200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.745600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.52677999999407E-05 |
| Normal-vs-Age(81-100Yrs) |
1.004360E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.284000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.388200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.761700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.076300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.195200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.949200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.21279999999391E-05 |
| Normal-VS-Type2 PRCC |
6.601100E-04 |
| Normal-VS-KIRP CIMP |
9.826200E-02 |
| Normal-VS-Unclassified PRCC |
2.944800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.915000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.3790000000028E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
9.322400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.984900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.281240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.565700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.28510000000104E-05 |
| Normal-vs-N1 |
1.338200E-01 |
| Normal-vs-N2 |
2.155900E-02 |
| N0-vs-N1 |
4.835000E-04 |
| N0-vs-N2 |
8.503600E-01 |
| N1-vs-N2 |
8.442200E-02 |
|
|
